# treatment for rheumatoid arthritis.

As the examples illustrate, incumbent strengths come to the fore

in the corridor of uncertainty. But the leadership team deciding

whether to make signiÔ¨Åcant investments needs to evaluate whether the

innovation team is answering the four questions with quality insights

and experimental evidence or merely with market chatter. That is the

only way to know if an innovation is truly ready to be scaled up.